TNFSF11 and prostate carcinoma: Immune cells, such as Tregs, Th17 cells, and macrophages, are also involved in prostate cancer progression while cytokines, such as IL-6 and RANKL, secreted by cells in the TME have been found to have a pleiotropic effect on prostate cancer cells [125].